North Carolina · 91304

Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use in North Carolina

North Carolina Medicare Avg
$144.81
2% above national avg
National Medicare Avg
$142.52
All states combined
Billed Charge (NC)
$166.64
What providers submit
Est. Commercial (NC)
$315.69
National avg: $319.25
Est. Cash / Self-Pay (NC)
$154.43
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

587
Services in NC
156
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in North Carolina

Provider Medicare Services
Costco Wholesale Corporation $145.24 27
Publix North Carolina Lp $145.24 23
Publix North Carolina, Lp $145.24 22

North Carolina Pricing in Context

In North Carolina, CPT code 91304 (Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use) carries an average Medicare payment of $144.81 — 2% above the national benchmark of $142.52. 156 providers across the state submitted claims for this procedure in 2023, performing 587 total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in North Carolina is $166.64, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Vaccines & Injections procedures, the estimated commercial insurance price in North Carolina lands near $315.69, with self-pay cash prices typically around $154.43. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use cost in North Carolina?

The average Medicare payment for Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use in North Carolina is $144.81, which is 2% above the national average of $142.52. Providers in NC typically bill $166.64 for this procedure.

What does Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use cost with insurance in North Carolina?

With commercial insurance in North Carolina, Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use costs an estimated $315.69. Without insurance, the estimated cash price is $154.43. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use in North Carolina?

156 providers in North Carolina billed Medicare for Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use in 2023, performing 587 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use cheaper in North Carolina than the national average?

No — Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use costs 2% above the national average in North Carolina. The state average Medicare payment is $144.81 compared to $142.52 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial